Sheba’s researchers are optimistic that patients will continue to respond favorably to Zantrene as the trial progresses, reporting results as they are analyzed over the study period so that the treatment can be approved for integration into regular clinical use as soon as possible.
Sheba’s researchers are optimistic that patients will continue...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.000(0.00%) |
Mkt cap ! $289.7M | |||
| Open | High | Low | Value | Volume |
| $1.70 | $1.70 | $1.66 | $85.03K | 50.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21581 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 4979 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |